New funding opportunity launching in May 2019
Our ambition is to stop prostate cancer from killing thousands of men each year. Every man diagnosed with the disease should receive the most effective treatment for their cancer. To achieve this, we need to add new treatment options to our arsenal, and to be smarter with how and when we use these therapies to achieve maximum effect.
In May 2019, we will be launching a funding call for research groups to investigate the immunology of prostate cancer, and strategies which may increase the success and impact of immunotherapeutic approaches in the future. Full details about this call will be released over the coming weeks, so please keep an eye out for further announcements.